In human glioblastoma cells (GBMs), RBBP4 depletion results in sensitization of tumor cells to temozolomide (TMZ) in conjunction with the downregulation of DNA repair protein Rad51 (54). This evidence concerns the gene XRCC6P5 and neoplasm.